Skip to main content
. 2020 Jul 30;11:1089. doi: 10.3389/fphar.2020.01089

Figure 5.

Figure 5

Therapy of NSCLC xenografts with B7-H3 CAR-NK-92MI cells. (A) Treatment procedures of NOD/SCID mice inoculated subcutaneously with A549 cells. (B) Tumor growth in NOD/SCID mice with treatments of CAR-NK-92MI cells compared to NK-92MI cells (**p < 0.01) and PBS (***p = 0.001). (C) Survival of mice by Kaplan-Meier survival analysis for CAR-NK-92MI cells compared to NK-92MI cells (*p < 0.05) and PBS (**p < 0.01). n = 5 each group.